Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption

被引:1372
作者
Altmann, SW
Davis, HR
Zhu, LJ
Yao, XR
Hoos, LM
Tetzloff, G
Iyer, SPN
Maguire, M
Golovko, A
Zeng, M
Wang, LQ
Murgolo, N
Graziano, MP
机构
[1] Schering Plough Corp, Res Inst, Dept Cardiovasc Endocrine Res, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Dept Discovery Technol, Kenilworth, NJ 07033 USA
关键词
D O I
10.1126/science.1093131
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dietary cholesterol consumption and intestinal cholesterol absorption contribute to plasma cholesterol levels, a risk factor for coronary heart disease. The molecular mechanism of sterol uptake from the lumen of the small intestine is poorly defined. We show that Niemann-Pick C1 Like 1 (NPC1L1) protein plays a critical role in the absorption of intestinal cholesterol. NPC1L1 expression is enriched in the small intestine and is in the brush border membrane of enterocytes. Although otherwise phenotypically normal, NPC1L1-deficient mice exhibit a substantial reduction in absorbed cholesterol, which is unaffected by dietary supplementation of bile acids. Ezetimibe, a drug that inhibits cholesterol absorption, had no effect in NPC1L1 knockout mice, suggesting that NPC1L1 resides in an ezetimibe-sensitive pathway responsible for intestinal cholesterol absorption.
引用
收藏
页码:1201 / 1204
页数:4
相关论文
共 30 条
  • [21] START: a lipid binding domain in StAR, HD-ZIP and signalling proteins
    Ponting, CP
    Aravind, L
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (04) : 130 - 132
  • [22] Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
    Repa, JJ
    Turley, SD
    Lobaccaro, JMA
    Medina, J
    Li, L
    Lustig, K
    Shan, B
    Heyman, RA
    Dietschy, JM
    Mangelsdorf, DJ
    [J]. SCIENCE, 2000, 289 (5484) : 1524 - 1529
  • [23] Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia - Reversal by cholic acid feeding
    Repa, JJ
    Lund, EG
    Horton, JD
    Leitersdorf, E
    Russell, DW
    Dietschy, JM
    Turley, SD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 39685 - 39692
  • [24] Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235):: A designed, potent, orally active inhibitor of cholesterol absorption
    Rosenblum, SB
    Huynh, T
    Afonso, A
    Davis, HR
    Yumibe, N
    Clader, JW
    Burnett, DA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (06) : 973 - 980
  • [25] New contributions in sterol metabolism
    Schoenheimer, R.
    [J]. SCIENCE, 1931, 74 (1928) : 579 - 584
  • [26] Schulthess G, 1996, J LIPID RES, V37, P2405
  • [27] Schwarz M, 1998, J LIPID RES, V39, P1833
  • [28] Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
    Tobert, JA
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) : 517 - 526
  • [29] WEISER MM, 1973, J BIOL CHEM, V248, P2536
  • [30] Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8
    Yu, LQ
    York, J
    von Bergmann, K
    Lutjohann, D
    Cohen, JC
    Hobbs, HH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 15565 - 15570